CNBC’s ‘Ultimate Deals’ on DocuSign, Emcore, GuideWire Software – DocuSign (NASDAQ: DOCU), EMCORE (NASDAQ: EMKR)

On CNBC’s “Halftime Report Final Deal,” Bryn Talkington Necessary capital management theory Docusign, Inc. Docu Having crushed the final quarter, another strong quarter is expected. It’s a “great entry point,” she added.

On December 5, DocuSign reported third-quarter revenue of $754.8 million, beating the consensus estimate of $745.2 million. The company reported third-quarter adjusted earnings of 90 cents per share, beating analysts’ estimates of 87 cents per share, according to Benzinga Pro.

In the field of technology, Jason Sniper Odyssey Capital Advisors Says He Likes Emcore Corporation ikradding that it will play a role in data center construction.

On January 3, EMCORE’s sales exceeded fourth quarter sales.

Don’t forget to check out our previous market coverage here

In the healthcare sector, Jim Lebenthal cerity partner’s name UnitedHealth Group Incorporated Unh as his final deal.

In recent news, UnitedHealth Group on Jan. 23 confirmed a replacement to lead United Healthcare after the division’s former CEO was murdered in New York last month. UnitedHealth Group announced that Tim Noel will serve as CEO of the UnitedHealthCare business.

sort out transactions, Joseph M. Terranova Virtus Investment Partners Selects Guidewire Software, Inc. GWRE.

Goldman Sachs analyst Adam Hotchkiss backed his view on Jan. 23, initiating coverage on Guidewire Software with a buy rating and declaring a price target of $210.

Price action:

• DocuSign stock closed Friday’s session down 1.2% at $91.60.
• EMCORE shares were priced at $3.06 during Friday’s session.
• UnitedHealth shares closed at $532.51 on Friday.
• Guidewire Software shares a 0.7% stake and is priced at $205.96.

Check it out:

Image: shutterstock